Vectibix PI Appendix 2 (PI)

First Page		Document Content
Date: 2015-03-02 10:30:33 Colorectal cancer Panitumumab KRAS Oxaliplatin FOLFOX Chemotherapy Cetuximab Medicine Chemistry Bevacizumab		Vectibix PI Appendix 2 (PI) Add to Reading List Source URL: www.ema.europa.eu Download Document from Source Website File Size: 303,50 KB Share Document on Facebook

	TACTIC: Phase 2 trial of panitumumab, cisplatin and gemcitabine in biliary tract cancer The TACTIC trial is helping researchers answer an important health question. It is providing evidence on whether panitumumab (Vectib DocID: 1sxxH - View Document
	AbstractProspective multicenter phase II study of the anti-EGFR (epidermal growth factor receptor) antibody panitumumab (P) in patients with platinum pre-treated, advanced head and neck squamous cell cancer (HNSCC DocID: 1rVAJ - View Document
	ICECREAM: Cetuximab antibody treatment for colorectal cancer with a G13D gene mutation The ICECREAM trial has helped researchers answer an important health question. It has provided evidence that cetuximab alone is not a DocID: 1pJVg - View Document
	PAN01 biomarker poster ESMO 15.pdf DocID: 1pBTA - View Document
	ATTAX3: Panitumumab added to docetaxel, cisplatin, fluoropyrimidine in oesophagogastric cancer The ATTAX3 trial has helped researchers answer an important health question. It has provided evidence on the value of a new c DocID: 1p6wp - View Document